 - Plans for the patient to receive other concomitant antineoplastic therapy including standard fractionated radiotherapy, chemotherapy, biological therapy, vaccine therapy, and surgery. Patients may receive antineoplastic therapy at the discretion of their treating physician beginning 6 weeks after completion of protocol therapy. 